{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Nuvalent, Inc."},"Symbol":{"label":"Symbol","value":"NUVL"},"Address":{"label":"Address","value":"ONE BROADWAY,14TH FLOOR, CAMBRIDGE, Massachusetts, 02142, United States"},"Phone":{"label":"Phone","value":"+1 857 357-7000"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets."},"CompanyUrl":{"label":"Company Url","value":"https://www.nuvalent.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Benjamin Lane","title":"Senior Vice President-Technical Operations"},{"name":"Christopher D. Turner","title":"Chief Medical Officer"},{"name":"Henry Pelish","title":"Chief Scientific Officer"},{"name":"James R. Porter","title":"President, Chief Executive Officer & Director"},{"name":"Jeffrey Lee","title":"Head-Information Technologies"},{"name":"Philip Engel","title":"Head-Information Technology"},{"name":"Ruth Adams","title":"Vice President-Clinical Operations"},{"name":"Viola Zhu","title":"Head-Clinical Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}